Myriad Genetics Inc (MYGN) — Cash Flow Quality Index
Myriad Genetics Inc (MYGN) has a Cash Flow Quality Index of -1.60x as of September 2021. Operating cash flow of $-39.30 Million is below net income of $24.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Myriad Genetics Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Myriad Genetics Inc Cash Flow Quality Index (2008–2020)
Historical Cash Flow Quality Index for Myriad Genetics Inc across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Myriad Genetics Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Myriad Genetics Inc (2008–2020)
Year-by-year earnings quality comparison for Myriad Genetics Inc. For live market cap and the full company financial profile, see Myriad Genetics Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 18.20x | $83.70 Million | $4.60 Million | ▲ +0.0% |
| 2019 | 18.20x | $83.70 Million | $4.60 Million | ▲ +1992.7% |
| 2018 | 0.87x | $115.90 Million | $133.30 Million | ▼ -85.8% |
| 2017 | 6.10x | $106.20 Million | $17.40 Million | ▲ +330.1% |
| 2016 | 1.42x | $166.30 Million | $117.20 Million | ▼ -19.0% |
| 2015 | 1.75x | $140.50 Million | $80.20 Million | ▲ +62.3% |
| 2014 | 1.08x | $190.20 Million | $176.20 Million | ▼ -8.6% |
| 2013 | 1.18x | $173.90 Million | $147.20 Million | ▼ -6.6% |
| 2012 | 1.26x | $141.80 Million | $112.15 Million | ▼ -2.7% |
| 2011 | 1.30x | $130.83 Million | $100.71 Million | ▲ +27.6% |
| 2010 | 1.02x | $155.09 Million | $152.30 Million | ▲ +2.5% |
| 2009 | 0.99x | $84.04 Million | $84.61 Million | ▼ -54.2% |
| 2008 | 2.17x | $103.74 Million | $47.84 Million | — |